Related references
Note: Only part of the references are listed.Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Expression of Estrogen Receptor-α as a Prognostic Factor in Patients With Uterine Serous Carcinoma
Tomoko Sho et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
A Bispecific HER2-Targeting FynomAb with Superior Antitumor Activity and Novel Mode of Action
Simon Brack et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Miriam Lenhard et al.
BMC CANCER (2013)
Lack of Estrogen Receptor-α Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Elisabeth Wik et al.
CLINICAL CANCER RESEARCH (2013)
Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma
Zhang Gong-yi et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Expression of ER-α36, a Novel Variant of Estrogen Receptor in Endometrial Carcinoma and Its Clinical Significance
Lifang Sun et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2013)
Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma
Paulette Mhawech-Fauceglia et al.
GYNECOLOGIC ONCOLOGY (2013)
Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
Jutta Huvila et al.
GYNECOLOGIC ONCOLOGY (2013)
The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer
Gian Franco Zannoni et al.
HUMAN PATHOLOGY (2013)
Prognostic Role of Hormone Receptors in Ovarian Cancer A Systematic Review and Meta-Analysis
Dong Zhao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
C. Krakstad et al.
BRITISH JOURNAL OF CANCER (2012)
Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma
Shinichi Togami et al.
CANCER SCIENCE (2012)
Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression
Ashley S. Felix et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer
Taejong Song et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer
R. L. Moore et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Markers for individualised therapy in endometrial carcinoma
Helga B. Salvesen et al.
LANCET ONCOLOGY (2012)
ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective
Ruchi Saxena et al.
MEDICINAL RESEARCH REVIEWS (2012)
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
Manohar Pradhan et al.
VIRCHOWS ARCHIV (2012)
An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer
Jing Zou et al.
BMJ OPEN (2012)
Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
M. A. Voss et al.
BRITISH JOURNAL OF CANCER (2011)
Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
Allan L. Covens et al.
GYNECOLOGIC ONCOLOGY (2011)
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Progesterone: the ultimate endometrial tumor suppressor
Shujie Yang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
The different roles of ER subtypes in cancer biology and therapy
Christoforos Thomas et al.
NATURE REVIEWS CANCER (2011)
Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer
N. Mori et al.
BRITISH JOURNAL OF CANCER (2010)
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer
William M. Merritt et al.
CANCER BIOLOGY & THERAPY (2010)
The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas
Aylin Ege Gul et al.
DIAGNOSTIC PATHOLOGY (2010)
HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study
Mina Xu et al.
HISTOPATHOLOGY (2010)
Comparative Performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for Uterine Corpus Cancer
Sharyn N. Lewin et al.
OBSTETRICS AND GYNECOLOGY (2010)
Prognostic significance and clinical importance of estrogen receptor α and β in human endometrioid adenocarcinomas
Ioannis Mylonas
ONCOLOGY REPORTS (2010)
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer
G. E. Konecny et al.
BRITISH JOURNAL OF CANCER (2009)
EphA2 Overexpression Is Associated With Lack of Hormone Receptor Expression and Poor Outcome in Endometrial Cancer
Aparna A. Kamat et al.
CANCER (2009)
Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
Vincent Jongen et al.
GYNECOLOGIC ONCOLOGY (2009)
Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer
Vincent H. W. M. Jongen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
Ingeborg B. Engelsen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization
F. E. Odicino et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Prognostic significance of oestrogen receptor alpha (ERα) and beta (ERβ), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas
Naim Shabani et al.
EUROPEAN JOURNAL OF CANCER (2007)
Biological roles of estrogen and progesterone in human endometrial carcinoma - New developments in potential endocrine therapy for endometrial cancer
Kiyoshi Ito et al.
ENDOCRINE JOURNAL (2007)
Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
Meenakshi Singh et al.
GYNECOLOGIC ONCOLOGY (2007)
Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma
Sumika Saito et al.
CANCER SCIENCE (2006)
14-3-3σ in endometrial cancer -: A possible prognostic marker in early-stage cancer
K Ito et al.
CLINICAL CANCER RESEARCH (2005)
Amplification of c-erbB2 oncogene - A maior prognostic indicator in uterine serous papillaty carcinoma
AD Santin et al.
CANCER (2005)
Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization
AD Santin et al.
GYNECOLOGIC ONCOLOGY (2005)
Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer?
VHWM Jongen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
AD Santin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization.: Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and KI-67 protein expression, and outcome
G Peiró et al.
MODERN PATHOLOGY (2004)
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma
BM Slomovitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers
H Sakaguchi et al.
GYNECOLOGIC ONCOLOGY (2004)
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
B Mulac-Jericevic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Multivariate independent prognostic factors in endometrial carcinoma:: A clinicopathologic study in 181 patients:: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University
E Steiner et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Prognostic factors in breast cancer: Current and new predictors of metastasis
DF Hayes et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)
P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression
PJ Coronado et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)
Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression
E Sivridis et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
Analysis of estrogen receptor α and β in endometrial carcinomas:: Correlation with ERβ and clinicopathologic findings in 45 cases
H Utsunomiya et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2000)
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
B Mulac-Jericevic et al.
SCIENCE (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
DNA hypermethylation in tumorigenesis - epigenetics joins genetics
SB Baylin et al.
TRENDS IN GENETICS (2000)
The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding
PH Giangrande et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
